No Data
No Data
Craig-Hallum Maintains Delcath Systems(DCTH.US) With Buy Rating
Eagle Financial Services, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Delcath Systems Receives FDA Clearance Of IND Application For Phase 2 Clinical Trial Of HEPZATO In Liver-Dominant Metastatic Breast Cancer
Express News | Delcath Systems Inc - Primary Endpoint Results Expected by End of 2028
Express News | Delcath Systems Announces FDA Clearance of Ind Application for Phase 2 Clinical Trial of Hepzato™ in Liver-Dominant Metastatic Breast Cancer
Press Release: Delcath Systems to Host First Quarter 2025 Earnings Call